The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of NKTR-214 on the number and activity of CD8+ tumor infiltrating lymphocytes in patients with advanced renal cell carcinoma.
 
Michael E. Hurwitz
Employment - Pfizer
Consulting or Advisory Role - Nektar
 
Adi Diab
Consulting or Advisory Role - Celgene; CureVac; Nektar
Research Funding - Celgene (Inst); Idera (Inst); Nektar (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Nektar
 
Chantale Bernatchez
Employment - Lexicon (I)
Stock and Other Ownership Interests - Lexicon (I)
Consulting or Advisory Role - Lion Biotechnologies
Research Funding - Idera; Nektar
Patents, Royalties, Other Intellectual Property - Patent pending on BTLA as a marker for better CD8 T cells for adoptive immunotherapy
 
Cara L. Haymaker
Research Funding - Idera; Nektar
 
Harriet M. Kluger
Honoraria - Merck
Consulting or Advisory Role - Alexion Pharmaceuticals; Prometheus; Regeneron
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Michael T. Tetzlaff
No Relationships to Disclose
 
Ivan Gergel
Employment - Nektar
Leadership - Corium International; Nektar
Stock and Other Ownership Interests - Corium International; Nektar
 
Mary Tagliaferri
Travel, Accommodations, Expenses - Nektar
 
Michael Imperiale
Employment - Nektar
Stock and Other Ownership Interests - Nektar
 
Sandra Aung
Employment - Nektar
Stock and Other Ownership Interests - Nektar
 
Ute Hoch
Employment - Nektar
Stock and Other Ownership Interests - Nektar
 
Jonathan Zalevsky
No Relationships to Disclose
 
Patrick Hwu
Stock and Other Ownership Interests - immatics; Lion Biotechnologies
Consulting or Advisory Role - Lion Biotechnologies
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst)
 
Mario Sznol
Stock and Other Ownership Interests - Adaptive Biotechnologies; Amphivena; Intensity Therapeutics
Consulting or Advisory Role - Adaptimmune; Alexion Pharmaceuticals; Amgen; AstraZeneca/MedImmune; Biodesix; Bristol-Myers Squibb; Genentech/Roche; Immune Design; Immune Design; Janssen Oncology; Kyowa Hakko Kirin; Lilly; Lion Biotechnologies; Lycera; Merck Sharp & Dohme; Merus; Modulate Pharma; Nektar; Novartis; pfizer; Symphony Evolution; Theravance; Vaccinex
Other Relationship - AcademicCME; Clinical Care Options; Dava Oncology; Haymarket Media; Imedex; Physicans' Education Resource; Prime Oncology; Research to Practice; TRM Oncology; Vindico
 
Nizar M. Tannir
Honoraria - Bristol-Myers Squibb; Exelixis; GlaxoSmithKline; Nektar; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Exelixis; GlaxoSmithKline; Nektar; Novartis
Research Funding - Bristol-Myers Squibb; Epizyme; Exelixis; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Exelixis; GlaxoSmithKline; Nektar; Novartis; Pfizer